JAMES HO: Open Payments
NPI 1891701223 · JAMAICA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$878 in 42 payments from 12 companies in 2025. Trend: 2023 $822 · 2024 $463 · 2025 $878
Food & beverage: $878
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 14 | $270 |
| ViiV Healthcare Company | 8 | $152 |
| E.R. Squibb & Sons, L.L.C. | 3 | $82 |
| Lilly USA, LLC | 3 | $81 |
| ABBVIE INC. | 3 | $70 |
| Merck Sharp & Dohme LLC | 3 | $65 |
| Alkermes, Inc. | 3 | $60 |
| Indivior Inc. | 1 | $24 |
| EMD Serono, Inc. | 1 | $23 |
| Lundbeck LLC | 1 | $19 |
Products named: DOVATO, COBENFY, MOUNJARO, VRAYLAR, GARDASIL 9, ARISTADA, APRETUDE, Biktarvy.
Industry payments across NY — which companies pay providers there.
